Hyperpolarized Carbon-13 Alpha-ketoglutarate Imaging in IDH Mutant Glioma
Status:
Recruiting
Trial end date:
2026-04-30
Target enrollment:
Participant gender:
Summary
This study will investigate the use of hyperpolarized (HP) carbon-13 (13C)
alpha-ketoglutarate (aKG) (HP 13C-aKG) to characterize tumor burden in patients with
isocitrate dehydrogenase (IDH) mutant glioma.